<img height="1" width="1" style="display:none" src="https://www.facebook.com/tr?id=234748540252369&amp;ev=PageView&amp;noscript=1">

Diopsys Insights

William Ayliffe, FRCS, PHD

Professor Will Ayliffe is one of the most experienced ophthalmologists in the world. Soon after starting Medical School, it became apparent that his skills with a microscope and his passion about all things visual were only going to fulfilled as an Eye Surgeon. After a satisfying and demanding apprenticeship with the most famous surgeons in Europe and the U.S.A he returned to the UK as a consultant for the NHS. After 20 years he became fully private, allowing him to choose and work with the best colleagues, support staff and Nurses while enabling access to the latest equipment and a wider choice of treatments to bespoke care towards the patient. He is a comprehensive ophthalmologist and a specialist in cataract but also is fellowship trained in cornea, uveitis and inflammatory eye diseases. He has performed many thousands of successful operations to restore sight in and was a pioneer in the field of micro-incision surgery using sub 2mm incisions and the use of realistic iris prosthetic implants for badly damaged eyes. He also operates for a variety of other blinding conditions, including corneal disease needing transplants, glaucoma and macular degeneration. Professor Ayliffe is Emeritus Professor of Physic at Gresham College, Honorary Professor at City University and a Consultant Ophthalmologist at the Lister and London Bridge Hospitals in London, and Spire St Anthony’s and Shirley Oaks in Surrey. As well as being a busy practising clinician and teacher, he also continues to carry out clinical research into the prevention of blindness. After taking a first in Immunology at Imperial College, he qualified in Medicine in St. Bartholomew’s Hospital London. Specialising in inflammatory eye diseases and corneal and cataract surgery he held a research registrar post studying the natural history, classification and treatments for cataract at Oxford University. After several publications and completion of this project, he completed training in clinical ophthalmology at Bristol, Manchester and Harvard University, USA. The PhD thesis was on mechanisms of corneal transplant failure. Prof. Ayliffe has worked in many clinics in emerging economies around the globe, and with ORBIS, the international flying eye hospital. In addition to general ophthalmology, he has developed a local and tertiary referral service for cornea, uveitis and inflammatory eye disease.

Recent Posts

The Gold Standard for Uveitis Treatment Management

Posted by William Ayliffe, FRCS, PHD on December 3, 2018 at 2:02 PM

INTRODUCTION:

Broadly speaking, uveitis is inflammation affecting the uveal tract, although management and prognosis for vision loss differs significantly according to what part of the eye is affected (i.e., anterior, posterior, intermediate, or panuveitis). Thus, prompt identification and localizing of inflammation is critically important, even though early indicators of active disease are often subtle and may not be apparent on clinical examination or on imaging.

For patients with uveitis and suspected retinal involvement, results from a flicker electroretinogram (flicker ERG) are extremely useful for making a diagnosis and monitoring disease activity. Clinicians can identify retinal dysfunction early then see functional improvement on the flicker ERG after the introduction of anti-inflammatory treatment with steroids or immunomodulatory therapy. An improvement in retinal function can indicate the plausibility of tapering the drug dosage.

Read More

Topics: Flicker ERG

Retina Focus: How Do You Know if Treatment is Working?

Posted by William Ayliffe, FRCS, PHD on March 5, 2018 at 3:43 PM

The utility of objective, quantitative metrics for making treatment decisions.

INTRODUCTION:

Determining the effectiveness of treatment in a patient with suspected retinal pathology can be challenging. While visual acuity can serve as a benchmark, vision gains do not necessarily correlate with improvement in structure or global function. Despite the array of diagnostic modalities available to the eye care expert, very few of them deliver actionable information that is helpful in deciding if treatment is working, when to change course, or perhaps even when to cease treatment because risks outweigh the potential benefits.

Read More

Topics: Flicker ERG

Modern Visual Electrophysiology

World Leading Technology

As the world leader in modern visual electrophysiology, Diopsys, Inc. has done more than any other company to advance the use of ERG and VEP in the eye care practice. Read through our blog to gain valuable insights into the benefits and integration of this valuable technology.

Subscribe to Email Updates

Recent Posts